Unterehmen auf Watchlist setzen
Teladoc Health
ISIN: US87918A1051
WKN: A14VPK
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Teladoc Health · ISIN: US87918A1051 · PR Newswire (ID: 20240710DC58677)
10 Juli 2024 08:59PM

TDOC Investors Have Opportunity to Lead Teladoc Health, Inc. Securities Fraud Lawsuit


NEW YORK, July 10, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds investors a shareholder filed a class action lawsuit on behalf of all purchasers of common stock of Teladoc Health, Inc. (NYSE: TDOC) between November 2, 2022 and February 20, 2024. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by July 16, 2024.

To join the Teladoc class action, go to https://rosenlegal.com/submit-form/?case_id=6818 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com.

The Rosen Law Firm is investigating the Allegations that Teladoc Health, Inc. (NYSE: TDOC) Misled Investors Regarding its Business Operations.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Teladoc continued to expand its marketing spend throughout 2023, despite public assurances that it would pull back its advertising spending; (2) increased marketing spend on BetterHelp, a Company division and online counseling service, deteriorated Teladoc's revenue, with little return for that investment; (3) despite Teladoc's acknowledgment that increased advertising spend would be marginally inefficient due to market saturation, it continued to grow its advertising spend in the BetterHelp business; and (4) despite public statements that there remained "a long runway" for BetterHelp membership growth, BetterHelp's membership stagnated and then decreased in 2023, due to market saturation, largely due to BetterHelp's own marketing. When the true details entered the market, the lawsuit claims that investors suffered damages.

What Now: You may be eligible to participate in the class action against Teladoc Health, Inc. The deadline to file a motion to be appointed as lead plaintiff is July 16, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, go to https://rosenlegal.com/case/teladoc-health-inc/

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

case@rosenlegal.com

www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tdoc-investors-have-opportunity-to-lead-teladoc-health-inc-securities-fraud-lawsuit-302193803.html

SOURCE THE ROSEN LAW FIRM, P. A.

Visuelle Wertentwicklung / Kursverlauf · Teladoc Health
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942